[ORGANIZATION]
ICBMT 2026
Featured in 1 tracked story · first seen
Situations
GC Cell advances GCC2005 CAR-NK therapy development
3 clusters · 6 sources · last updated
Latest: GC Cell presents GCC2005 clinical trial results at ICBMT 2026
GC Cell is advancing its GCC2005 CAR-NK cell therapy, a CD5-targeted allogeneic treatment for refractory T-cell lymphoma. The company has partnered with QuantHealth to use AI-based clinical trial simulations to optimize